AlphaStocks
2.9
Avoid

Collegium Pharmaceutical, Inc (COLL)

As of Sep 20, 2026, Collegium Pharmaceutical, Inc (COLL) scores 2.9/10 on AlphaStocks' five-model composite, #156 of 168 Health Care stocks.

Health Care / Pharmaceuticals

S&P SmallCap 600

$22.79

Scores poorly across most models. Proceed with caution.

Avoid

Score based on 5 of 5 models — high confidence

Data as of Sep 20, 2026

#156out of 168 in Health Care

Is COLLEGIUM PHARMACEUTICAL, INC a Good Investment in 2026?

COLLEGIUM PHARMACEUTICAL, INC (COLL) scores 2.9 out of 10 on AlphaStocks' composite model, earning a Avoid rating. The Greenblatt Magic Formula model rates COLLEGIUM PHARMACEUTICAL, INC as Strong (Earnings yield 10.3% · ROC 68%). However, the Graham model rates it Caution — 49% above fair value. COLLEGIUM PHARMACEUTICAL, INC ranks #156 out of 168 stocks in the Health Care sector.

This summary is algorithmically generated and is not financial advice.

Key Metrics

P/E14.4ROE10.2Market Cap913.1M

Valuation

Trades at 14x earnings — near sector median of 30x.

Fair value estimate not available for this stock.

5-Model Analysis

Each model evaluates this stock from a different angle. Combined, they form the composite score above.

Piotroski

Attractive

6/9

Buffett

Neutral

Business quality & competitive moat

Graham

Caution

49% above fair value

Lynch

Neutral

PEG 1.0 · Fast Grower

Greenblatt

Strong

Earnings yield 10.3% · ROC 68%

Frequently Asked Questions

Is COLLEGIUM PHARMACEUTICAL, INC (COLL) a good investment?
As of Sep 20, 2026, Collegium Pharmaceutical, Inc (COLL) scores 2.9/10 on AlphaStocks' five-model composite, #156 of 168 Health Care stocks. That score is below average, suggesting caution. Trades at 14x earnings — near sector median of 30x.
What is COLLEGIUM PHARMACEUTICAL, INC's Piotroski F-Score?
COLLEGIUM PHARMACEUTICAL, INC's Piotroski F-Score status is Attractive. The raw score is 6/9. The Piotroski F-Score evaluates financial health using 9 fundamental signals including profitability, leverage, and operating efficiency.
Is COLL overvalued or undervalued?
A precise fair value estimate is not available for COLL. Trades at 14x earnings — near sector median of 30x.
How does COLL compare to other Health Care stocks?
COLLEGIUM PHARMACEUTICAL, INC ranks #156 out of 168 stocks in the Health Care sector, placing it in the top 93% of its sector by composite score. There are higher-ranked alternatives in this sector worth exploring.
What do investment models say about COLL?
AlphaStocks evaluates COLL using five proven investment models. Piotroski: Attractive; Buffett: Neutral; Graham: Caution; Lynch: Neutral; Greenblatt Magic Formula: Strong. These models are combined into a single composite score of 2.9/10.

Similar Stocks

AMPHLLYACAD

Compare COLL with

AMPH vs COLLCOLL vs LLYACAD vs COLLCOLL vs PARRCOLL vs VAL

Scores are algorithm-generated research tools, not investment recommendations. Past performance does not guarantee future results. Always do your own due diligence. Full disclaimer